A team of neurologists and population health scientists from New York University (NYU) has issued a call to action to reduce deaths from epilepsy. They call for educational interventions and public health campaigns targeting medication adherence, psychiatric comorbidity, and other modifiable risk factors.
A recent study shows that 80% of multiplex families with epilepsy could be successfully classified into clinical syndromes using molecular genetics. Understanding the genetic component of epilepsy could strengthen genetic counseling and provide opportunity for improved intervention.
Analysis of clinical trials and a retrospective analysis of insurance claims data related to patients with epilepsy using eslicarbazepine acetate (Aptiom) were presented at the 2015 American Epilepsy Society annual meeting. The analysis demonstrated that eslicarbazepine acetate imparts quality-of-life benefits, improves depression, and reduces hospitalizations in patients with partial-onset seizures.
Results 1 - 3 of 3